Tandem Diabetes Care, Inc. (TNDM) Operating cash flow 2016–2025
Tandem Diabetes Care, Inc. (TNDM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.7MFY2025 · since FY2016: -$61.2M → -$9.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.7M | -140.1% |
| FY2024 | $24.2M | +176.2% |
| FY2023 | -$31.8M | -163.0% |
| FY2022 | $50.5M | -54.7% |
| FY2021 | $111.4M | +351.4% |
| FY2020 | $24.7M | -41.1% |
| FY2019 | $41.9M | +603.7% |
| FY2018 | -$8.3M | +87.4% |
| FY2017 | -$66.1M | -8.1% |
| FY2016 | -$61.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TNDM financial trends
TNDM RevenueTNDM Net incomeTNDM Net marginTNDM Gross profitTNDM Gross marginTNDM Operating incomeTNDM Operating marginTNDM Free cash flowTNDM Capital expendituresTNDM Return on equityTNDM Stock buybacksTNDM Dividends paidTNDM Total assetsTNDM Total liabilitiesTNDM Shareholders’ equityTNDM overview →